We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EVN:ASXEvolution Mining Limited Analysis

Data as of 2026-08-17 - not real-time

A$13.89

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Evolution Mining Limited trades at AUD 13.89, with its moving averages tangled rather than clearly stacked — a neutral trend structure. It has gained 10.2% over the past 30 days. RSI sits at 65.6, which reads as approaching overbought, and MACD momentum is bullish. Price has been bracketed by support at AUD 10.31 and resistance at AUD 14.08.
Valuation screens as overvalued, on a P/E of 21.0 with no clean sector comparison available. Sell-side targets cluster 8.2% below the current quote. Revenue is growing at 37.5% on a 26.0% profit margin. The 3.03% dividend yield looks covered by current payout levels.
The composite risk read is 7/10, putting it in elevated territory. With 30-day volatility of 52.2%, a beta of 1.06 and a maximum drawdown of 41.7%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.

Top Market Events

Evolution Mining Ltd ASX:EVN  has agreed to acquire Carnaby Resources Ltd ASX:CNB, FRA:1FI in an all-scrip transaction...Australian shares closed higher on Monday, as a fall in oil prices provided relief over inflation coEvolution Mining Ltd ASX: EVN shares have continued falling further into the red today.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Trading above the 200-day average of 12.83
  • MACD momentum is positive
  • 30-day price change of +10.2%

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Trading above the 200-day average of 12.83
  • Analyst targets imply -8.2% versus the current price
  • 30-day volatility of 52.2%

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Analyst targets imply -8.2% versus the current price
  • Profit margin of 26.0% is healthy
  • Revenue growth of +37.5%

Key Metrics & Analysis

Financial Health

Revenue Growth37.50%
Profit Margin25.97%
P/E Ratio21.0
ROE26.39%
ROA13.25%
Debt/Equity26.41
P/B Ratio5.0
Op. Cash FlowA$2.4B
Free Cash FlowA$1.2B

Technical Analysis

TrendNeutral
RSI65.6
SupportA$10.31
ResistanceA$14.08
MA 20A$12.30
MA 50A$12.07
MA 200A$12.83
MACDBullish
VolumeStable
Fear & Greed Index94.73

Valuation

Fair ValueA$19.99
Target PriceA$12.75
Upside/Downside-8.19%
GradeOvervalued
TypeBlend
Dividend Yield3.03%

Risk Assessment

Beta1.06
Volatility52.17%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.